OakChart

Alphatec Holdings Inc

ATECHealthcare·Medical Devices·USA·Small·NASD·Nov 11 • 2:06 PM ET

7.32+0.32 (4.50%)
2026-11-11 20:07 CET
Market cap
1,085.98 USD m
Revenue, TTM
839.72 USD m
Net income, TTM
-86.89 USD m
Free cash flow, TTM
3.07 USD m
EPS diluted, TTM
-0.56
P/E
-
Compare

Price

ATEC against its 20, 50 and 200-day averages
2050200beatmiss
8.0010.0012.0014.0013.6M27.3MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26ATECclose 7.3220-day 9.3850-day 9.84200-day 10.207.3252w low

68.6% under the 52-week high of 23.29 on 8 Jan 2026. 52-week low 6.81 on 30 Oct 2026. Last 15 sessions, 79.1% high to low

Profile

ATEC
52-week range, 3% of the way up
6.8123.29

Alphatec Holdings, Inc. engages in the design, development, and marketing of spinal fusion technology products and solutions for the treatment of spinal disorders. The firm offers intra-operative information and neuromonitoring technologies, access systems, interbody implants, fixation systems, and various biologics offerings. It operates through the United States and International geographical segments. The company was founded on March 4, 2005, and is headquartered in Carlsbad, CA.

IndexRUT
Employees913
IPOJun 02, 2006
Beta0.87
ATR, 14d0.70
Rel volume1.47
Short float11.75%
Insider own21.80%
Inst own75.26%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap1.13B
Enterprise Value1.67B
Income-86.89M
Sales839.72M
Book/sh-0.02
Cash/sh0.52
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees913
IPOJun 02, 2006

Ratios

P/E-
Forward P/E12.99
PEG0.09
P/S1.35
P/B-
P/C14.20
P/FCF369.66
EV/EBITDA28.72
EV/Sales1.99
Quick Ratio1.22
Current Ratio2.36
Debt/Eq27.88
LT Debt/Eq27.48
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.56
EPS next Y0.56
EPS next Q0.12
EPS this Y488.32%
EPS next Y91.50%
EPS next 5Y152.68%
EPS past 3/5Y13.26% 4.12%
Sales past 3/5Y29.62% 39.46%
EPS Y/Y TTM46.31%
Sales Y/Y TTM15.34%
EPS Q/Q81.57%
Sales Q/Q12.55%
EarningsOct 29 AMC
EPS/Sales Surpr.-5.36% -1.77%

Ownership

Insider Own21.80%
Insider Trans0.99%
Inst Own75.26%
Inst Trans-0.65%
ROA-10.97%
ROE-308.06%
ROIC-14.32%
Gross Margin61.90%
Oper. Margin-3.05%
Profit Margin-10.35%
SMA20-22.02%
SMA50-25.65%
SMA200-28.28%
Trades-

Technical

Shs Outstand153.41M
Shs Float121.32M
Short Float11.75%
Short Ratio4.62
Short Interest14.25M
52W High23.29 -68.59%
52W Low6.81 7.42%
Volatility7.43% 6.53%
ATR (14)0.70
RSI (14)35.41
Beta0.87
Rel Volume1.47
Avg Volume3.08M
Volume3,279,629

Performance

Perf Week-11.65%
Perf Month-32.39%
Perf Quarter-24.97%
Perf Half Y-3.11%
Perf YTD-65.23%
Perf Year-64.70%
Perf 3Y-28.28%
Perf 5Y-37.37%
Perf 10Y55.64%
Recom1.29
Target Price13.29
Prev Close7.00
Price7.32
Change %4.50%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Nov 04, 2026DowngradeUUBSBuy → Neutral$8.50+16.2%
Oct 30, 2026DowngradeBBMO Capital MarketsOutperform → Market Perform$8+9.4%
Jul 28, 2026InitiatedUUBSBuy$15+105.1%
Jul 23, 2026InitiatedSStephensOverweight$15+105.1%
Jul 09, 2026InitiatedBBMO Capital MarketsOutperform$11+50.4%
Oct 28, 2025ResumedSStifelBuy$20+173.4%
Oct 24, 2025InitiatedJJP MorganOverweight$19+159.7%
Jun 16, 2025ResumedLLake StreetBuy$18+146.1%
Aug 01, 2024DowngradeMMorgan StanleyOverweight → Equal-Weight
Jul 08, 2024InitiatedBBarclaysOverweight$19+159.7%

Peers

Mkt cap
TickerCompanyMkt cap
GMEDGlobus Medical Inc9.91B
OFIXOrthofix Medical Inc292.45M
SIBNSI-BONE Inc1.12B
MDTMedtronic Plc129.36B
KIDSOrthoPediatrics corp881.36M
XTNTXtant Medical Holdings Inc38.93M
IARTIntegra Lifesciences Holdings Corp1.17B
ENOVEnovis Corp1.65B
SYKStryker Corp121.19B
ZBHZimmer Biomet Holdings Inc20.19B

Insider trading

latest 14 of 66
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Valentine KeithDirectorNov 10 '26Buy6.9335,000242,550299,283Nov 10 07:56 PM
Demski David MDirectorOct 30 '26Buy6.8160,000408,600491,635Nov 02 12:23 PM
Miles PatrickCEOSep 10 '26Buy8.81115,0001,013,1505,893,551Sep 10 08:58 PM
Marshall Tyson EliotGENERAL COUNSEL & CORP. SEC.Aug 05 '26Sale9.658,16878,821630,398Aug 07 08:25 PM
TYSON MARSHALLOfficerAug 05 '26Proposed Sale10.358,16884,539Aug 05 04:20 PM
MCGINNIS KAREN KDirectorJun 11 '26Sale8.016,05048,46094,671Jun 12 05:54 PM
MCGINNIS KAREN KDirectorJun 11 '26Proposed Sale8.016,05048,460Jun 11 11:04 AM
Valentine KeithDirectorMay 07 '26Buy7.4956,153420,586153,424May 11 07:00 PM
Valentine KeithDirectorMay 08 '26Buy7.5443,847330,606197,271May 11 07:00 PM
Valentine KeithDirectorMay 11 '26Buy7.0035,000245,000232,271May 11 07:00 PM
Marshall Tyson EliotGENERAL COUNSEL & CORP. SEC.Apr 07 '26Option Exercise2.52102,500258,050661,959Apr 09 05:42 PM
Koning John ToddCHIEF FINANCIAL OFFICERMar 13 '26Sale12.3679,789986,192600,721Mar 17 05:30 PM
Lish ScottCHIEF OPERATING OFFICERMar 13 '26Sale12.30260,5353,204,580815,704Mar 17 05:30 PM
Sponsel DavidEVP, SALESMar 11 '26Sale12.52163,4522,046,419504,932Mar 13 06:00 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
IHIiShares U.S. Medical Devices ETFAUM: 4.07B
VHTVanguard Health Care ETFAUM: 21.51B
FYCFirst Trust Small Cap Growth AlphaDEX FundAUM: 1.35B
FESMFidelity Enhanced Small Cap Core ETFAUM: 6.82B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-290.0900.095-0.030221.17225.1510
2026Q22026-08-040.0700.070-0.165213.51211.2610
2026Q12026-05-050.000-0.022-0.220192.11197.519
2025Q42026-02-240.0600.038-0.143212.93211.5410
2025Q32025-10-300.030-0.031-0.189196.5182.628
2025Q22025-07-310.020-0.044-0.275185.54178.787
2025Q12025-05-01-0.112-0.115-0.354169.18168.188
2024Q42025-02-26-0.034-0.054-0.231177172.768
2024Q32024-10-30-0.108-0.107-0.276150.72147.198
2024Q22024-07-31-0.143-0.116-0.285146144.558
2024Q12024-05-07-0.181-0.155-0.344138134.078
2023Q42024-02-27-0.111-0.073-0.367137.97131.97
2023Q32023-11-06-0.141-0.085-0.348118.26114.246
2023Q22023-08-03-0.113-0.190-0.433116.92109.99
2023Q12023-05-04-0.170-0.227-0.397109.11103.339
2022Q42023-02-28-0.105-0.204-0.331105.94102.1610

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-1.090-0.853-1.091113.43111.91
2020FY-1.180-1.026-1.179144.86144.22
2021FY-1.500-1.406-1.500243.21238.63
2022FY-0.622-0.666-1.464350.87346.45
2023FY-0.523-0.419-1.539482.26475.85
2024FY-0.398-0.441-1.134612607.33
2025FY0.0500.030-0.960764.16762.95
2026FY-0.294--864.84
2027FY-0.563--979.51
2028FY-0.807--1,107
2029FY-0.990--1,251
2030FY-1.590--1,551

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-0214012237.61233.8252.55
2026Q4S2026-10-3014011238.63233.8252.55
2026Q4S2026-10-291410251.51246.3253.07
2026Q4S2026-10-191410251.51246.3253.07
2026Q4S2026-10-161433251.51246.3253.07
2026Q4S2026-08-201423251.24246.3252.7
2026Q4S2026-08-111423251.23246.3252.7
2026Q4S2026-08-061423251.2246.3252.7
2026Q4S2026-08-051423251.22246.3252.7
2026Q4S2026-08-041400251.36248258.71
2026Q4S2026-07-301400251.35248258.71
2026Q4S2026-07-271400251.36248258.71
2026Q4S2026-07-211300251.32248258.71
2026Q4S2026-07-201200251.38248258.71

Estimate history

EPS, annual-0.179-1.202-1.091-1.179-1.5-1.464-1.539-1.134-0.955-0.5624
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.276-0.231-0.354-0.275-0.189-0.143-0.22-0.165-0.035
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual101.73991.694113.427144.861243.212350.867482.262611.562764.155839.72
Period201720182019202020212022202320242025TTM
Sales, quarterly150.719176.793169.18185.544196.503212.928192.108213.513221.172
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual19.85743.36861.482.10499.537106.64139.245144.129150.257153.412
Period201720182019202020212022202320242025MRQ
Shares, quarterly143.907144.129146.906147.034147.539150.257151.986152.683153.412
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue839.72764.15611.56482.26350.87243.21144.86113.4391.69
Cost of Goods Sold Incl. D&A319.91309.76265.72228.20158.98112.2153.3143.4129.20
Gross Profit519.81454.40345.84254.06191.89131.0191.5570.0262.50
Selling, General and Administrative Excl. Other545.39512.36468.76402.34312.99239.88137.64108.6882.49
Research and Development76.0276.2780.7270.1144.0332.0218.7513.859.98
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-25.57-57.97-122.91-148.28-121.10-108.87-46.09-38.67-19.99
Interest Expense46.1945.9224.8816.645.507.1112.37-7.14
Unusual Expense16.3741.1213.2625.1225.8728.3220.398.613.04
Net Income Before Taxes-88.69-143.40-162.07-186.91-152.01-144.16-78.85-57.14-30.17
Income Taxes-1.81-0.040.05-0.28-0.720.160.14-0.24-1.36
Consolidated Net Income-86.89-143.36-162.12-186.64-151.29-144.33-78.99-56.90-28.81
Net Income From Continuing Operations-86.89-143.36-162.12-186.64-151.29-144.33-78.99-56.90-28.81
Net Income-86.89-143.36-162.12-186.64-151.29-144.33-78.99-57.00-42.46
EPS (Recurring)-0.48-0.76-1.07-1.39-1.29-1.29-0.97-0.98-1.14
EPS (Basic, Before Extraordinaries)-0.56-0.96-1.13-1.54-1.46-1.50-1.18-1.09-1.20
EPS (Diluted)-0.56-0.96-1.13-1.54-1.46-1.50-1.18-1.09-1.20
EBITDA58.2424.60-39.59-88.59-77.17-78.70-34.46-30.16-13.21
Non-Operating Income (Expense)-0.551.60-1.023.120.470.140.00-9.870.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense59.3758.2457.8964.1832.0426.6112.898.004.46
Price To Sales Ratio1.934.132.153.803.644.526.723.270.88
Gross Margin61.9059.4656.5552.6854.6953.8663.2061.7368.16
Operating Margin-3.05-7.59-20.10-30.75-34.52-44.76-31.82-34.09-21.81
Net Margin-10.35-18.76-26.51-38.70-43.12-59.34-54.53-50.25-46.31
Shares Outstanding153.41150.26144.13139.25106.6499.5482.1061.4043.37
Market Capitalization1,085.981,085.981,301.432,059.511,297.471,134.921,138.74435.3698.96

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue221.17213.51192.11212.93196.50185.54169.18176.79
Cost of Goods Sold Incl. D&A83.3979.2174.7782.5478.3675.7773.0976.03
Gross Profit137.78134.30117.34130.39118.14109.7796.09100.77
Selling, General and Administrative Excl. Other133.94136.29139.40135.75127.56121.26127.80121.68
Research and Development18.0018.1717.5622.2818.6818.2816.5823.24
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income3.84-1.99-22.06-5.36-9.41-11.48-31.71-20.92
Interest Expense10.6210.9611.7212.8912.8812.317.847.15
Unusual Expense0.5911.800.533.466.5218.3812.762.90
Net Income Before Taxes-7.46-25.62-33.86-21.75-28.50-41.18-51.97-32.89
Income Taxes-1.990.160.05-0.020.07-0.04-0.060.44
Consolidated Net Income-5.47-25.78-33.91-21.73-28.58-41.14-51.91-33.33
Net Income From Continuing Operations-5.47-25.78-33.91-21.73-28.58-41.14-51.91-33.33
Net Income-5.47-25.78-33.91-21.73-28.58-41.14-51.91-33.33
EPS (Recurring)-0.03-0.11-0.22-0.13-0.16-0.19-0.29-0.22
EPS (Basic, Before Extraordinaries)-0.03-0.16-0.22-0.14-0.19-0.27-0.35-0.23
EPS (Diluted)-0.03-0.16-0.22-0.14-0.19-0.27-0.35-0.23
EBITDA25.5919.13-1.6015.1210.969.04-10.53-0.10
Non-Operating Income (Expense)-0.10-0.870.45-0.030.310.990.34-1.92
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense11.0214.3418.6915.3212.9412.3417.6317.01
Price To Sales Ratio1.931.662.134.193.022.442.322.17
Gross Margin62.3062.9061.0861.2460.1259.1656.8057.00
Operating Margin1.74-0.93-11.48-2.52-4.79-6.19-18.74-11.83
Net Margin-2.47-12.07-17.65-10.20-14.54-22.17-30.68-18.85
Shares Outstanding153.41152.68151.99150.26147.54147.03146.91144.13
Market Capitalization1,085.981,330.271,646.763,125.492,151.691,622.521,278.451,301.43

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments160.81138.84220.9784.70187.25107.7747.1129.0522.47
Short Term Receivables97.3082.9972.6160.0641.8924.6016.1515.4514.82
Inventories169.44175.26136.84101.5291.7046.0034.8528.7727.29
Other Current Assets23.3220.3120.679.3610.315.7910.202.271.90
Total Current Assets450.88417.40451.09255.63331.16184.16108.3275.5466.48
Net Property, Plant & Equipment166.55191.09176.25130.31112.6837.8521.5813.2312.67
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Long-Term Note Receivable----0.004.005.005.005.00
Intangible Assets168.66164.49175.45130.15124.9638.6239.5040.305.25
Other Assets5.122.722.424.873.250.600.550.400.26
Total Assets791.21775.71805.21520.97572.05265.22174.95134.4889.66
Short Term Debt Incl. Current Port. of LT Debt70.828.116.9719.794.555.081.803.283.31
Accounts Payable40.8952.9848.9834.7425.7417.607.774.403.88
Income Tax Payable------0.08--
Other Current Liabilities107.4691.93101.6284.3470.8035.6326.7322.9422.56
Total Current Liabilities219.18153.03157.57138.87101.0958.3136.3930.6129.74
Long Term Debt525.27601.83534.71376.07350.8738.0854.3742.3037.77
Provision for Risks Charges0.000.005.846.535.118.010.000.000.00
Other Liabilities10.7411.425.3710.5611.953.3511.9515.3920.21
Total Liabilities755.18766.28703.49532.03469.03107.74102.7188.3087.72
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value23.6023.6023.6023.6023.6023.6023.6023.6023.60
Common Equity12.43-14.1778.12-34.6779.42133.8848.6322.57-21.66
Total Shareholders Equity36.039.43101.72-11.06103.03157.4872.2346.181.95
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity36.039.43101.72-11.06103.03157.4872.2346.181.95
Total Liabilities & Stockholders Equity791.21775.71805.21520.97572.05265.22174.95134.4889.66
Book Value Per Share0.08-0.100.56-0.330.801.630.790.52-1.09
Tangible Book Value Per Share-1.04-1.24-0.70-1.55-0.461.160.15-0.41-1.35
Full-Time Employees913867839705561296227195138
Price to Book Ratio-466.36-970.40-42.19-57.4514.328.908.964.40-1.41
Return on Assets-18.30-20.51-28.31-27.68-34.48-35.89-36.78-25.71-4.81
Return on Equity-630.66-291.71-421.26-329.04-110.80-68.78-96.11-119.73-
Return on Invested Capital-25.54-26.52-29.33-41.45-31.80-40.39-45.02-32.75-5.78
Quick Ratio1.281.581.991.112.372.372.021.531.32
Current Ratio2.062.732.861.843.283.162.982.472.24

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-86.89-143.36-162.12-186.64-151.29-144.33-78.99-57.00-28.98
Depreciation83.8182.5683.3259.6843.9330.1711.638.516.79
Other Funds (Non Cash)134.43137.58101.43102.6556.1764.6036.8924.197.70
Funds from Operations131.3576.7922.62-24.31-51.20-49.56-30.46-24.74-15.89
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-70.01-31.56-67.27-54.18-23.94-23.88-15.95-8.38-9.71
Cash from Operating Activities61.3445.23-44.65-78.48-75.13-73.43-46.41-33.12-25.61
Capital Expenditures-71.78-49.64-93.14-86.97-58.28-68.54-23.89-13.03-6.91
Net Assets From Acquisitions0.000.000.00-55.000.00-62.130.000.00-15.10
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.030.000.35
Purchase or Sale of Investments0.00-3.000.000.000.00-24.100.000.000.00
Purchase of Investments0.00-3.000.000.000.00-24.100.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses-8.38-0.770.000.000.00-2.990.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-80.16-53.41-93.14-141.97-58.28-157.76-23.86-13.03-21.67
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock1.210.52-0.56212.12-3.04100.86111.0455.8351.90
Repurchase of Common Pref Stock0.000.000.000.000.00-25.000.000.000.00
Sale of Common Pref Stock1.210.52-0.56212.12-3.04125.86111.0455.8351.90
Proceedsfrom Stock Options1.210.52-0.56212.12-3.04125.86111.0455.8351.90
Issuance or Reduction of Debt, Net-8.1674.1158.66146.3433.69221.3619.798.361.98
Change in Long Term Debt-132.78-50.5158.66146.3433.69221.3619.798.361.98
Issuance of Long Term Debt-146.5913.45222.84279.1561.19306.2276.46124.41124.54
Reduction of Long Term Debt13.81-63.96-164.18-132.81-27.50-84.87-56.67-116.05-122.55
Net Financing Active Other Cash Flow-49.84-44.60-1.89-1.530.58-10.260.000.000.00
Other Financing Activities Uses-49.84-44.60-1.89-1.530.00-10.260.000.000.00
Cash from Financing Activities-56.7830.0256.21356.9231.23311.97130.8364.1853.88
Exchange Rate Effect-0.210.13-0.55-0.18-0.37-1.290.090.03-0.02
Net Change in Cash-75.8121.97-82.13136.27-102.5579.4860.6518.066.59
Free Cash Flow3.072.78-127.87-158.99-124.59-141.98-69.54-46.15-32.52
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.00-
Price to Free Cash Flow529.721,137.37-------
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.01-0.44-1.41

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments79.94118.66139.91160.81155.74157.06
Short Term Receivables120.91117.73112.7997.30100.5999.89
Inventories206.87194.89186.03169.44166.89169.76
Other Current Assets19.4417.7417.4423.3216.5616.62
Total Current Assets427.17449.01456.17450.88439.78443.33
Net Property, Plant & Equipment187.42168.42168.65166.55170.84173.65
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets170.42162.46164.49168.66171.24170.81
Other Assets11.7411.1210.175.125.392.51
Total Assets796.75791.03799.48791.21787.25790.29
Short Term Debt Incl. Current Port. of LT Debt8.6471.6172.1770.8271.118.43
Accounts Payable61.6362.1046.0440.8936.8847.24
Other Current Liabilities110.50104.25122.03107.46112.8498.51
Total Current Liabilities180.77237.97240.24219.18220.82154.18
Long Term Debt585.30532.41530.89525.27520.05578.20
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities9.379.1110.0910.7411.2710.54
Total Liabilities775.44779.49781.22755.18752.14742.92
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value23.6023.6023.6023.6023.6023.60
Common Equity-2.30-12.07-5.3512.4311.5123.77
Total Shareholders Equity21.3011.5318.2636.0335.1147.37
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity21.3011.5318.2636.0335.1147.37
Total Liabilities & Stockholders Equity796.75791.03799.48791.21787.25790.29
Book Value Per Share-0.02-0.08-0.040.080.080.16
Tangible Book Value Per Share-1.13-1.14-1.12-1.04-1.08-1.00
Full-Time Employees---913--
Price to Book Ratio-466.36-245.88131.56269.7889.94-18.97
Return on Assets-10.97-13.91-15.82-18.30-20.21-21.30
Return on Equity-308.06-373.44--630.66-540.40-376.89
Return on Invested Capital-0.90-4.74-6.17-3.87-5.15-6.58
Quick Ratio1.221.071.121.281.241.77
Current Ratio2.361.891.902.061.992.88

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-5.47-25.78-33.91-21.73-28.58-41.14
Depreciation21.7521.1220.4620.4820.3820.52
Other Funds (Non Cash)22.7844.8235.3731.4628.5143.31
Funds from Operations39.0640.1621.9230.2120.3122.69
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-20.20-19.65-20.62-9.53-6.27-7.14
Cash from Operating Activities18.8620.511.2920.6814.0415.55
Capital Expenditures-20.41-22.09-14.31-14.96-10.89-12.17
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.00-3.000.00
Purchase of Investments0.000.000.000.00-3.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses-1.41-0.62-5.58-0.770.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-21.81-22.71-19.89-15.73-13.89-12.17
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.002.17-2.171.21-0.052.36
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.002.17-2.171.21-0.052.36
Proceedsfrom Stock Options0.002.17-2.171.21-0.052.36
Issuance or Reduction of Debt, Net-33.25-16.77-0.2542.11-0.33-1.10
Change in Long Term Debt-33.25-16.77-0.25-82.51-0.33-1.10
Issuance of Long Term Debt30.00210.522.75-389.863.372.99
Reduction of Long Term Debt-63.25-227.29-2.99307.35-3.70-4.09
Net Financing Active Other Cash Flow-2.44-4.920.64-43.12-0.93-0.89
Other Financing Activities Uses-0.63-6.080.00-43.12-0.93-0.56
Cash from Financing Activities-35.69-19.53-1.770.21-1.310.37
Exchange Rate Effect-0.090.48-0.52-0.09-0.160.08
Net Change in Cash-38.73-21.25-20.895.07-1.323.82
Free Cash Flow5.570.58-10.807.724.815.22
Price to Free Cash Flow529.72587.07241.201,152.85610.47-

Revenue breakdown

Surgical & Medical Instruments & Apparatus2024: 611.56M 2025: 764.16M
Non-US2024: 40.30M 2025: 48.01M
United States2024: 571.27M 2025: 716.14M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3011.75%14.3M121.3M2.78M
2026-10-1511.00%13.3M120.8M2.19M
2026-09-3011.63%14.1M121.0M2.21M
2026-09-1512.33%14.4M117.0M2.54M
2026-08-3111.58%13.7M118.1M2.51M
2026-08-1411.54%13.6M118.1M2.70M
2026-07-3111.34%13.8M121.6M3.37M
2026-07-1511.36%13.7M121.1M3.57M
2026-06-3012.07%14.6M121.1M3.52M
2026-06-1510.21%12.4M121.0M3.18M
2026-05-299.96%12.0M120.5M3.22M
2026-05-1512.21%14.2M116.1M3.28M
2026-04-3010.26%11.9M116.2M2.60M
2026-04-1512.28%14.0M114.4M2.64M
2026-03-3112.95%14.9M115.5M3.08M
2026-03-1313.27%15.3M115.5M3.01M
2026-02-2711.90%13.7M115.5M2.91M
2026-02-1312.38%14.3M115.5M2.78M
2026-01-3012.80%14.5M113.5M2.93M
2026-01-1514.63%16.6M113.4M2.78M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.504.105.300.007.4950.000.000.978-0.0140.001
call5.001.852.802.303.5661.000.000.944-0.0120.001
call7.500.000.300.450.8434290.000.443-0.0210.005
call10.000.000.100.051.5671701.000.125-0.0210.002
call12.500.000.050.051.9601,3050.000.058-0.0150.001
call15.000.000.250.162.40417.000.000.049-0.0160.001
call17.500.001.500.022.8731.000.000.043-0.0170.001
call20.000.000.050.093.19030.000.000.040-0.0180.001
put2.500.000.750.004.0870.000.00-0.022-0.0140.001
put5.000.000.050.093.3290.000.00-0.152-0.0510.003
put7.500.300.450.550.7494510.00-0.557-0.0200.005
put10.002.203.403.023.2754130.00-0.876-0.0200.002
put12.503.407.105.506.9651.000.00-0.942-0.0130.001
put15.007.108.807.765.8901.000.00-0.951-0.0140.001
put17.509.6011.1010.385.9771.000.00-0.957-0.0150.001
put20.0011.7014.1012.697.5950.000.00-0.960-0.0160.001

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-104Statement of changes in beneficial ownership of securities2026-11-10SEC
2026-11-024Statement of changes in beneficial ownership of securities2026-10-30SEC
2026-10-2910-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-298-KCurrent report2026-10-29SEC
2026-10-054Statement of changes in beneficial ownership of securities2026-10-05SEC
2026-09-243Initial statement of beneficial ownership of securities2026-09-14SEC
2026-09-104Statement of changes in beneficial ownership of securities2026-09-10SEC
2026-08-074Statement of changes in beneficial ownership of securities2026-08-05SEC
2026-08-05144Filing for proposed sale of securities under Rule 144.SEC
2026-08-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-04S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-08-048-KCurrent report2026-08-04SEC
2026-06-124Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-124Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-124Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-124Statement of changes in beneficial ownership of securities2025-06-10SEC
2026-06-124Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-11144Filing for proposed sale of securities under Rule 144.SEC
2026-06-11S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-06-118-KCurrent report2026-06-10SEC
2026-05-28SDSpecialized Disclosure ReportSEC
2026-05-114Statement of changes in beneficial ownership of securities2026-05-07SEC
2026-05-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-058-KCurrent report2026-05-01SEC
2026-04-29ARSAnnual report to security holders. 2025-12-31SEC
2026-04-29DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-04-29DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-06-10SEC
2026-04-094Statement of changes in beneficial ownership of securities2026-04-07SEC
2026-03-174Statement of changes in beneficial ownership of securities2026-03-13SEC
2026-03-174Statement of changes in beneficial ownership of securities2026-03-13SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-11242.55K100
2026-10408.60K100
2026-091.01M100
2026-080078.82K1
2026-070000
2026-060048.46K1
2026-05996.19K300
2026-040000
2026-03008.79M6
2026-02001.38M2
2026-01002.10M1
2025-120031.20M17
2025-110049.04M12

Institutional holders

Manager% owned
ABSOLUTE INVESTMENT ADVISERS, LLC9.39%
BlackRock, Inc.7.37%
BRAIDWELL LP4.25%
AMERICAN CENTURY COMPANIES INC4.24%
VANGUARD CAPITAL MANAGEMENT LLC3.33%
BNP Paribas Asset Management Holding S.A.2.30%
STATE STREET CORP2.26%
JACOBS LEVY EQUITY MANAGEMENT, INC2.18%
GEODE CAPITAL MANAGEMENT, LLC2.13%
ROYAL BANK OF CANADA1.95%

Funds

Fund% owned
iShares Convertible Bond ETF5.55%
State Street(R) SPDR(R) Bloomberg Convertible Securities ETF4.32%
CALAMOS CONVERTIBLE & HIGH INCOME FUND3.96%
CALAMOS CONVERTIBLE OPPORTUNITIES & INCOME FUND3.80%
Calamos Convertible Fund3.80%
Small Cap Growth Fund3.19%
Calamos Dynamic Convertible & Income Fund3.14%
VANGUARD TOTAL STOCK MARKET INDEX FUND2.37%
iShares Russell 2000 ETF2.10%
Advent Convertible & Income Fund2.02%

OakChart. ATEC. Cached 15 minutes.